New insulin injection tested in major diabetes trial
NCT ID NCT05834868
Summary
This study tested whether a new insulin injection called THDB0206 works as well as a standard insulin combination for controlling blood sugar in people with type 2 diabetes. It involved over 1,000 Chinese adults who were already using insulin. The main goal was to see if the new insulin could lower long-term blood sugar levels (HbA1c) as effectively as the standard treatment over 26 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.